Log in
Enquire now
‌

US Patent 11867687 Methods of BH3 profiling

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118676870
Patent Inventor Names
Jeremy Ryan0
Anthony Letai0
Date of Patent
January 9, 2024
0
Patent Application Number
169191730
Date Filed
July 2, 2020
0
Patent Citations
‌
US Patent 11225511 BH3 peptides and methods of use thereof
0
‌
US Patent 10761086 High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
0
‌
US Patent 11215608 Methods of determining cellular chemosensitivity
0
‌
US Patent 7064193 Therapeutic molecules
0
‌
US Patent 7714005 Small molecule Bcl-xL/Bcl-2 binding inhibitors
0
‌
US Patent 7868133 BH3 peptides and method of use thereof
0
‌
US Patent 8221966 Methods of determining cellular chemosensitivity
0
‌
US Patent 8466140 Mitochondria-targeted anti-tumor agents
0
...
Patent Primary Examiner
‌
Gailene Gabel
0
CPC Code
‌
G01N 33/5748
0
‌
G01N 33/582
0
‌
G01N 33/5011
0
‌
G01N 2800/52
0
‌
G01N 33/5079
0
‌
G01N 2333/82
0
‌
G01N 33/5035
0
Patent abstract

The present invention provides methods of determining cell sensitivity to a therapeutic agent.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11867687 Methods of BH3 profiling

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.